Síguenos en Twitter     Síguenos en Facebook     Síguenos en Google+     Síguenos en YouTube     Siguenos en Linkedin     Correo Grupsagessa     Gmail     Yahoo Mail     Dropbox     Instagram     Pinterest     Slack     Google Drive     Reddit     StumbleUpon     Print

SOBRE EL AUTOR **

Mi foto
FACP. Colegio de médicos de Tarragona Nº 4305520 / fgcapriles@gmail.com

WORLD EMERGENCY MEDICINE SOCIETIES

Buscar en contenido

Contenido:

viernes, 31 de marzo de 2017

Diabetic Gastroparesis

R.E.B.E.L.EM - March 30, 2017
Ref. Ramirez R et al. Haloperidol Undermining Gastroparesis Symptoms (HUGS) in the Emergency Department. AJEM 2017 [epub ahead of print]
"Background: Anyone practicing in emergency medicine has taken care of a patient with diabetic gastroparesis. Although, it is not a sexy topic to discuss, nor a disease process associated with significant mortality, it is associated with decreased quality of life, and increased resource utilization due to frequent hospitalization. Furthermore, opioid analgesia, can further decrease gastric emptying and therefore worsen symptoms of abdominal pain and nausea/vomiting. Haloperidol possesses antiemetic and analgesic properties, which may be one of the reasons this medication could work in diabetic gastroparesis. The authors of this paper quite ingeniously entitled their study: Haloperidol Undermining Gastroparesis Symptoms (HUGS)...
Author Conclusion: “The rate of admission and ME was found to be significantly reduced in patients with GP secondary to diabetes mellitus who received HP. HP may represent an appropriate, effective, and safe alternative to traditional analgesia and antiemetic therapy in the ED management of GP associated N/V/AP.”
Clinical Take Home Point: In this small, retrospective study, 5mg IM Haldol decreased rates of admission and amounts of opioids administered in patients with diabetic gastroparesis. Haldol could be a potential addition to the armamentarium of treatment in this difficult to treat disease process."